COVID-19 Map - Johns Hopkins Coronavirus Resource Center
Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19. This website is a resource to help advance the understanding of the virus, inform the public, and brief policymakers in order to guide a response, improve care, and save lives.
Home - Johns Hopkins Coronavirus Resource Center
The Hub — the news and information website for Johns Hopkins — publishes the latest updates on COVID-19 research about vaccines, treatments, and public health measures.
News & Resources - Johns Hopkins Coronavirus Resource Center
Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19. Important information and updates from the experts and researchers at Johns Hopkins.
JN.1, the Dominant Variant in the COVID Surge | Johns Hopkins ...
Jan 9, 2024 · JN.1 is now the dominant variant in the U.S., causing over 60% of COVID cases. The good news: Vaccines, tests, and antivirals are effective against it.
Coronavirus | Johns Hopkins Medicine
Get updates on the number of COVID-19 patients at Johns Hopkins Medicine care facilities. We are closely collaborating with the U.S. Centers for Disease Control and Prevention as well as the Maryland Department of Health to help ensure the well-being of …
Coronavirus (COVID-19) Articles - Johns Hopkins Medicine
Johns Hopkins faculty members, staff, and medical students are using their expertise with infectious disease and prevention to treat patients infected with COVID to help lessen the spread of COVID-19.
COVID 19 Daily Report | Johns Hopkins Medicine
Daily update about the number of patients who test positive for COVID-19 and the number of patients hospitalized for COVID-19 in our hospitals.
What you need to know about JN.1, the latest COVID variant
Jan 12, 2024 · Here, Pekosz explains what virologists are seeing, what this new variant means for case rates and treatments, and why it's so important for more people to get the updated COVID-19 vaccine rolled out this fall. What is JN.1?
Johns Hopkins-Led Study Finds Convalescent Plasma Can Be …
Mar 30, 2022 · The research showed that high-titer (antibody-rich) COVID convalescent plasma—when administered to COVID-19 outpatients within nine days after testing positive—reduced the need for hospitalization for more than half of the study’s predominantly unvaccinated outpatients.
Trump picks Johns Hopkins surgeon who argued against COVID ... - ABC News
1 day ago · Johns Hopkins Medicine As restrictions eased and a new variant surfaced, virus-related deaths soared from about 4,000 a week to about 15,000 a week by September, making 2021 a deadlier year than ...